Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Hui Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4772-9483; OpenAlex author ID A5017332714, A5121305308. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 4

  1. Dynamics of Circulating Tumor DNA (ctDNA) Predict Treatment Efficacy and Prognosis in Patients With Advanced Pancreatic Cancer: A Prospective Large-Cohort Stud… First author DOI 10.1002/mco2.70829↗
  2. Inhibition of Gemcitabine-Induced Autophagy in Cancer-Associated Fibroblasts Reduces Collagen I and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer. First author DOI 10.1177/15473287261442512↗
  3. [Comparison of adjuvant S-1 plus gemcitabine with S-1 monotherapy for pancreatic adenocarcinoma: real-world data]. Co-author DOI 10.3760/cma.j.cn112152-20250310-00103↗
  4. Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cance… Co-author DOI 10.3389/fimmu.2023.1170223↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingting You · 3 shared papers, 2025–2026 · strength 0.87
  2. Chunmei Bai · 3 shared papers, 2025–2026 · strength 0.87
  3. Dongfeng Song · 2 shared papers, 2026 · strength 0.60
  4. Robert Chunhua Zhao · 1 shared paper, 2026 · strength 0.32
  5. Yingyi Wang · 1 shared paper, 2026 · strength 0.29
  6. Yuejuan Cheng · 1 shared paper, 2026 · strength 0.29
  7. Xin Li · 1 shared paper, 2023 · strength 0.18
  8. Wenkai Jiang · 1 shared paper, 2023 · strength 0.18
  9. Hui Zhang · 1 shared paper, 2023 · strength 0.18
  10. Shi Dong · 1 shared paper, 2023 · strength 0.18
  11. Wence Zhou · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.